These data demonstrate the importance of CTNNB1 genetic testing and should indicate that patients with WNT-activated medulloblastomas CTNNB1 wild type must be monitored by a multidisciplinary team, due to possible hereditary nature of the disease and propensity to develop other tumor types. The gene discussed is CTNNB1; the disease is neoplasm.